Ghana

Collaboration between PATH and the Ghana Health Service Institutional Care Division scales-up use of the STREAM™ Disinfectant Generator in health facilities.

The Digital Innovation in Pandemic Control (DIPC) project, launched in November 2022, is a collaborative initiative led by GIZ and Digital Square at PATH to strengthen immunization systems in Ghana, Malawi, and Tanzania. In response to the fragmentation and lack of interoperability exposed during the COVID‑19 pandemic, DIPC works closely with country health ministries to select, localize, and implement digital public health tools—such as Electronic Immunization Registries and WHO SMART-based Digital Adaptation Kits—to build scalable, interoperable, and locally sustainable immunization platforms. Through end-to-end ecosystem mapping, system enhancement, and capacity building, the project aims to create resilient, digitally enabled immunization workflows that can support both routine vaccination and future pandemic preparedness across participating countries by 2025.

To improve sustainability and strengthen the readiness of digital immunization systems for future pandemics, the Deutsche Gesellschaft für Internationale Zusammenarbeit (GIZ)’s Digital Innovation in Pandemic Control (DIPC) project works with ministries of health to select, adapt, and scale the use of robust digital tools.As an implementing partner of the DIPC project, Digital Square at PATH uses its expertise to create models for improved and more sustainable pandemic-prepared health systems with a focus on immunization workflows. Digital Square is working with three partner countries: Ghana, Malawi, and Tanzania. The following resources capture Digital Square’s support to Ghana within the DIPC project.

PATH’s HPV Vaccine Safety, Immunogenicity, and Health Economics (HPV SIHE) project is coming to a close after five years—and it leaves a long list of successes behind.

Results from a Phase 3 clinical study of Innovax’s WHO prequalified vaccine can help expand access globally and give countries another option for affordable, sustainable HPV vaccine.

When countries consider introducing new vaccines, immunization program cost and affordability are key questions. Data are limited on what vaccinating pregnant populations costs. To help fill this gap, PATH conducted prospective studies in collaboration with ministries of health and other partners to understand cost of delivery and introduction implications for new vaccines given in pregnancy in Bangladesh, Ghana, Kenya, Mozambique, and Nepal. The estimates will help inform policy decisions in low- and middle-income countries where maternal immunization-preventable diseases often hit hardest.Find here links to the peer-reviewed journal articles and fact sheets summarizing the research from Kenya, Ghana, and Mozambique. Publication of the Bangladesh and Nepal results is forthcoming. (Materials available in English and, as applicable, in Portuguese.)

PATH is sponsoring a Phase 3 clinical study is to generate immunogenicity data for one dose of Innovax 9vHPV vaccine compared to a one dose of GARDASIL 9, with the prospect of providing evidence for another nine-valent vaccine product option for single-dose vaccination.

Integrated antenatal care eLearning courseTo address the critical challenges of neonatal and maternal mortality, Ghana Health Service and PATH expanded infectious disease screening and treatment among pregnant women through the Integrated Antenatal Care project (2022‒2024).One key output of this project is an eLearning course designed to build health care providers’ capacity to improve the overall quality of care, including diagnosis, prevention, and management of maternal infections in pregnant women during antenatal care visits. It also fosters demand creation for intervention and services available in health facilities. The course’s overall goal is to contribute to the reduction of morbidity and mortality attributable to infections in newborns by improving the diagnosis and management of maternal infections during antenatal care.The course includes the following modules:1. Infection prevention and control2. Point of care and other diagnostics3. Clinical features and management of selected infections in pregnant women4. Antimicrobial resistance and stewardship5. Standard operating procedures for infection control and management during antenatal careThe document linked below provides a course overview. For more information, please contact Gideon Sarpong Nyamekye.

How the government, PATH, and many partners are working together to save the lives of newborns.

The trial aimed to determine how well a new, injectable, non-replicating rotavirus vaccine candidate works, compared to a licensed oral rotavirus vaccine in preventing infant diarrhea.